Skip to content

GPs Companies Pricing About Sign in Start free

GP Intel.

Open-data private equity intelligence. 1,000+ European PE firms, 21,000+ portfolio companies, verified exits. Finally done right.

Product

GP Database
Companies
Features
Pricing

Discover

By country
By sector
By strategy
Rankings
Blog
Glossary

Company

About
Methodology
Editorial standards
FAQ
Press
Contact

© 2026 GP Intel. All rights reserved.

Mimetas. Healthcare | Current Portfolio of Merieux Equity Partners (2020) | GP Intel

Home/Companies/Healthcare/Mimetas

MI

Mimetas

Healthcare·Europe·Active·6yr hold

Mimetas is a healthcare company, headquartered in Europe.

Entry

2020

Hold

6yr

Status

Active

Est. EV

–

Investor

Merieux Equity Partners

Sign in to see fund context

Key facts

HQEurope

SectorHealthcare

StatusActive

Netherlands-based developer of organ-on-a-chip platforms for predictive drug testing.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Already a member? Sign in

More from Mérieux Innovation 1

Other portfolio companies in the same fund.

Broken String Biosciences

HealthcareEurope· 2023

HealthcareEurope· 2023

HealthcareEurope

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Advent International

A Place for Mom

Last updated May 2026 · Sourced from public filings

· 2023

HealthcareEurope· 2022

Mablink Bioscience

HealthcareEurope· 2022

SeqOne Genomics

HealthcareEurope· 2022

Abacus Pharmaceuticals

The Carlyle Group

Abbisko Healthcare

The Carlyle GroupChina